Nines Receives FDA Clearance for Lung-Nodule Measurement Solution

March 31, 2021

Nines has been granted 510(k) clearance by the FDA for NinesMeasure, an artificial intelligence (AI)-based lung-nodule measurement tool for diagnosis of respiratory diseases.

The tool, which was developed by a collaborative team of radiologists and engineers, can help radiologists accelerate the measurement of pulmonary nodules, improving time to diagnosis for certain respiratory conditions.

The company also received FDA clearance in April 2020 for AI technology that identifies intracranial hemorrhages and mass effect conditions that can cause injury to brain tissue.

View today's stories